IRWD vs PSA · P/E 5.7, rev $219.5M vs rev $1.23B
Ironwood Pharmaceuticals Inc (IRWD) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
Ironwood Pharmaceuticals Inc (IRWD) is a drug manufacturers - specialty & generic company listed on NASDAQ.
PSA (PSA) common stock.
Latest reported IRWD revenue for 2026-06-30 was $219.5M. Net income was $92.1M. IRWD currently screens at market cap $579.4M and trailing P/E 5.7.
Latest reported PSA revenue for 2026-06-30 was $1.23B. Net income was $500.0M. Revenue was up 1.2% from 2026-03-31 to 2026-06-30. PSA currently screens at market cap $0.
IRWD currently screens at market cap $579.4M and trailing P/E 5.7. PSA currently screens at market cap $0.
Not investment advice. Open the IRWD and PSA stock pages for the full models.
Not investment advice.